Aslıhan Avanoğlu Güler

970 total citations
41 papers, 591 citations indexed

About

Aslıhan Avanoğlu Güler is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aslıhan Avanoğlu Güler has authored 41 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aslıhan Avanoğlu Güler's work include Inflammasome and immune disorders (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Aslıhan Avanoğlu Güler is often cited by papers focused on Inflammasome and immune disorders (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Aslıhan Avanoğlu Güler collaborates with scholars based in Türkiye, United States and Italy. Aslıhan Avanoğlu Güler's co-authors include Abdurrahman Tufan, Marco Matucci‐Cerinic, Hazan Karadeniz, Mehmet Akif Öztürk, Hasan Satış, Reyhan Bilici Salman, Berna Göker, Nuh Ataş, Hakan Babaoğlu and Şeminur Haznedaroğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Aslıhan Avanoğlu Güler

39 papers receiving 576 citations

Peers

Countries citing papers authored by Aslıhan Avanoğlu Güler

Since Specialization

Citations

This map shows the geographic impact of Aslıhan Avanoğlu Güler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslıhan Avanoğlu Güler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslıhan Avanoğlu Güler more than expected).

Fields of papers citing papers by Aslıhan Avanoğlu Güler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aslıhan Avanoğlu Güler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslıhan Avanoğlu Güler. The network helps show where Aslıhan Avanoğlu Güler may publish in the future.

Co-authorship network of co-authors of Aslıhan Avanoğlu Güler

This figure shows the co-authorship network connecting the top 25 collaborators of Aslıhan Avanoğlu Güler. A scholar is included among the top collaborators of Aslıhan Avanoğlu Güler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aslıhan Avanoğlu Güler. Aslıhan Avanoğlu Güler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD 2025 ·Biomarkers in Medicine ·(unknown), (unknown), (unknown), Aslıhan Avanoğlu Güler, Hazan Karadeniz, Özlem Gülbahar, Abdülsamet Erden, Abdurrahman Tufan, Mehmet Akif Öztürk, Berna Göker, Şeminur Haznedaroğlu, Hamit Küçük	1
2	Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 2024 ·Seminars in Arthritis and Rheumatism ·Aslıhan Avanoğlu Güler, Corrado Campochiaro, Giacomo De Luca, Michael Hughes, Abdurrahman Tufan, (unknown), Francesco Del Galdo, Marco Matucci‐Cerinic, Lorenzo Dagna	3
3	Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 2024 ·International Journal of Molecular Sciences ·Aslıhan Avanoğlu Güler, Giacomo De Luca, Lorenzo Dagna, (unknown), Corrado Campochiaro	0
4	The Effect of Telerehabilitation‐Based Self‐Management Programme on Individuals With Scleroderma 2024 ·Musculoskeletal Care ·(unknown), (unknown), Aslıhan Avanoğlu Güler, Deran Oskay, Çiğdem Öksüz	1
5	Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy 2024 ·International Immunopharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hazan Karadeniz, Aslıhan Avanoğlu Güler, Hamit Küçük, Abdülsamet Erden, Berna Göker, Mehmet Akif Öztürk, Abdurrahman Tufan	2
6	Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study 2023 ·Seminars in Arthritis and Rheumatism ·Hazan Karadeniz, Murat Uçar, (unknown), (unknown), Aslıhan Avanoğlu Güler, (unknown), (unknown), (unknown), (unknown), (unknown), M. Karadeniz, Abdülsamet Erden, Hamit Küçük, Berna Göker, Mehmet Akif Öztürk, Abdurrahman Tufan	5
7	Systemic sclerosis and interstitial lung disease: From pathogenesis, to screening, diagnosis, and classification 2023 ·Revista Colombiana de Reumatología ·(unknown), Aslıhan Avanoğlu Güler, Corrado Campochiaro, Marco Matucci‐Cerinic, I. Castellví	0
8	Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD 2023 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·Hazan Karadeniz, Aslıhan Avanoğlu Güler, (unknown), M. Karadeniz, Hatîce Paşaoğlu, (unknown), Berna Göker, (unknown), Mehmet Akif Öztürk	2
9	Effects of interleukin-1 antagonists on de novo and pre-existing damage in patients with familial Mediterranean fever 2022 ·Clinical and Experimental Rheumatology ·(unknown), (unknown), (unknown), Hazan Karadeniz, Aslıhan Avanoğlu Güler, (unknown), Hamit Küçük, Berna Göker, Mehmet Akif Öztürk, Abdurrahman Tufan	1
10	Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients 2022 ·SHILAP Revista de lepidopterología ·Hazan Karadeniz, (unknown), Aslıhan Avanoğlu Güler, Reyhan Bilici Salman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emetullah Cındıl	3
11	The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis 2022 ·Clinical Rheumatology ·Nuh Ataş, (unknown), Fatih Bakır, Murat Uçar, Hasan Satış, (unknown), (unknown), Hakan Babaoğlu, Reyhan Bilici Salman, Aslıhan Avanoğlu Güler, Hazan Karadeniz, Şeminur Haznedaroğlu, Berna Göker, Mehmet Akif Öztürk, Abdurrahman Tufan	4
12	Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography 2021 ·Modern Rheumatology ·Reyhan Bilici Salman, (unknown), (unknown), Dilek Yapar, Hakan Babaoğlu, Hasan Satış, Aslıhan Avanoğlu Güler, Hazan Karadeniz, Nuh Ataş, Hamit Küçük, Ümit Özgür Akdemir, Şeminur Haznedaroğlu, Abdurrahman Tufan, Berna Göker, Hatîce Paşaoğlu, Lütfiye Özlem Atay, Mehmet Akif Öztürk	3
13	Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists 2021 ·Clinical Rheumatology ·(unknown), Nuh Ataş, Aslıhan Avanoğlu Güler, (unknown), Hakan Babaoğlu, Hasan Satış, Hazan Karadeniz, Şeminur Haznedaroğlu, Mehmet Akif Öztürk, Abdurrahman Tufan	5
14	COVID-19 in Chronic Diseases 2020 ·Gazi Medical Journal ·Aslıhan Avanoğlu Güler, Mehmet Akif Öztürk, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
15	COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs 2020 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·Abdurrahman Tufan, Aslıhan Avanoğlu Güler, Marco Matucci‐Cerinic	344
16	Determination of the Voice Parameters in Adult Individuals With Rheumatoid Arthritis and the Relation of Voice With Depression and Inflammation 2020 ·Journal of Voice ·(unknown), (unknown), Hazan Karadeniz, Aslıhan Avanoğlu Güler, Dilek Yapar, Mehmet Akif Öztürk, Metin Yılmaz	1
17	Parotid elastography: a potential alternative to replace labial biopsy in classification of patients with primary Sjögren’s syndrome? 2020 ·Clinical Rheumatology ·Hasan Satış, Emetullah Cındıl, Reyhan Bilici Salman, Dilek Yapar, (unknown), (unknown), Hakan Babaoğlu, Nuh Ataş, Hazan Karadeniz, Aslıhan Avanoğlu Güler, Suna Özhan Oktar, Abdurrahman Tufan, Mehmet Akif Öztürk, Şeminur Haznedaroğlu, Berna Göker	8
18	The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis 2020 ·Frontiers in Immunology ·Aslıhan Avanoğlu Güler, Francesca Wanda Rossi, Silvia Bellando-Randone, Nella Prevete, Abdurrahman Tufan, Mirko Manetti, Amato de Paulis, Marco Matucci‐Cerinic	5
19	Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study 2019 ·Rheumatology International ·Nuh Ataş, Berkan Armağan, (unknown), Hasan Satış, Alper Sarı, Nazife Şule Yaşar Bilge, Reyhan Bilici Salman, G. K. Yardimci, Hakan Babaoğlu, Aslıhan Avanoğlu Güler, Hazan Karadeniz, Levent Kılıç, Mehmet Akif Öztürk, Berna Göker, Şeminur Haznedaroğlu, Umut Kalyoncu, Timuçin Kaşifoğlu, Abdurrahman Tufan	41
20	Hemophagocytic lymphohistiocytosis after certolizumab treatment in a patient with rheumatoid arthritis 2018 ·European Journal of Rheumatology ·Göksel Güven, Aslıhan Avanoğlu Güler, (unknown), (unknown), (unknown), Murat Turgay, Neriman Defne Altıntaş	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact